Barometer Capital Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-24,600
Closed -$1.03M 163
2020
Q2
$1.03M Buy
24,600
+5,600
+29% +$221K 0.19% 98
2020
Q1
$602K Buy
+19,000
New +$727K 0.18% 68
2018
Q4
Sell
-102,100
Closed -$4.02M 166
2018
Q3
$4.02M Sell
102,100
-108,800
-52% -$4.13M 0.31% 111
2018
Q2
$7.86M Buy
210,900
+6,500
+3% +$236K 0.66% 48
2018
Q1
$7M Buy
204,400
+128,300
+169% +$4.5M 0.59% 47
2017
Q4
$2.5M Sell
76,100
-8,000
-10% -$250K 0.23% 107
2017
Q3
$2.62M Buy
+84,100
New +$2.47M 0.25% 97

Other funds holding SBIO

Barometer Capital Management's SBIO Position: Q3 2020 in Review

Barometer Capital Management sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2020, closing a stake of 24,600 shares — an estimated $1.03M sold.

Barometer Capital Management first reported a position in SBIO in Q3 2017 and held it in 7 quarters. The position peaked at $7.86M in Q2 2018. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.

  • Barometer Capital Management reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2020 after selling out during the quarter.
  • Barometer Capital Management sold 24,600 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $1.03M.
  • Barometer Capital Management first reported a position in ALPS Medical Breakthroughs ETF in Q3 2017 and held it in 7 quarters.
  • Barometer Capital Management's ALPS Medical Breakthroughs ETF position peaked at $7.86M in Q2 2018.
  • 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.

Based on Barometer Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.